(MPTI) M-tron Industries - Overview
Exchange: NYSE MKT •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US55380K1097
Stock: Filters, Oscillators, Resonators, Amplifiers, Assemblies
Total Rating 44
Risk 99
Buy Signal -0.55
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 58.0% |
| Relative Tail Risk | -12.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.45 |
| Alpha | -5.93 |
| Character TTM | |
|---|---|
| Beta | 1.397 |
| Beta Downside | 1.325 |
| Drawdowns 3y | |
|---|---|
| Max DD | 49.99% |
| CAGR/Max DD | 1.64 |
Description: MPTI M-tron Industries January 18, 2026
M-tron Industries (MPTI) designs and manufactures frequency-control components-including RF, microwave, and millimeter-wave filters, a range of crystal oscillators (OCXO, TCXO, VCO), resonators, and solid-state power amplifiers-serving commercial aerospace, defense, space, avionics, and industrial customers worldwide. Founded in 1965 and based in Orlando, Florida, the firm operates within the Electronic Equipment & Instruments sub-industry.
In FY 2023 the company generated roughly $85 million in revenue, up about 12 % year-over-year, with a gross margin near 38 % and an operating backlog of $70 million, indicating solid demand continuity across its defense and commercial segments.
Key macro drivers for M-tron include rising U.S. defense spending (the FY 2024 defense budget grew 4 % YoY), accelerating deployment of 5G and satellite constellations that boost demand for high-performance RF filters and oscillators, and ongoing semiconductor supply-chain tightening that favors established niche suppliers with proven reliability.
For a deeper quantitative view, you may find the ValueRay platform’s MPTI analyst dashboard useful.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 7.16m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA -0.97 > 1.0 |
| NWC/Revenue: 56.33% < 20% (prev 41.23%; Δ 15.11% < -1%) |
| CFO/TA 0.23 > 3% & CFO 9.79m > Net Income 7.16m |
| Net Debt (-18.2m) to EBITDA (10.2m): -1.77 < 3 |
| Current Ratio: 6.90 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.92m) vs 12m ago 4.12% < -2% |
| Gross Margin: 44.40% > 18% (prev 0.45%; Δ 4395 % > 0.5%) |
| Asset Turnover: 143.7% > 50% (prev 149.1%; Δ -5.36% > 0%) |
| Interest Coverage Ratio: -21.24 > 6 (EBITDA TTM 10.2m / Interest Expense TTM -433.0k) |
Altman Z'' 10.00
| A: 0.71 (Total Current Assets 34.9m - Total Current Liabilities 5.06m) / Total Assets 42.2m |
| B: 0.39 (Retained Earnings 16.4m / Total Assets 42.2m) |
| C: 0.25 (EBIT TTM 9.20m / Avg Total Assets 36.9m) |
| D: 3.14 (Book Value of Equity 16.4m / Total Liabilities 5.22m) |
| Altman-Z'' Score: 10.87 = AAA |
Beneish M -3.51
| DSRI: 0.91 (Receivables 6.23m/6.06m, Revenue 53.0m/47.0m) |
| GMI: 1.02 (GM 44.40% / 45.30%) |
| AQI: 0.23 (AQ_t 0.01 / AQ_t-1 0.06) |
| SGI: 1.13 (Revenue 53.0m / 47.0m) |
| TATA: -0.06 (NI 7.16m - CFO 9.79m) / TA 42.2m) |
| Beneish M-Score: -3.51 (Cap -4..+1) = AAA |
What is the price of MPTI shares?
As of February 07, 2026, the stock is trading at USD 64.38 with a total of 21,551 shares traded.
Over the past week, the price has changed by -1.32%, over one month by +10.30%, over three months by +21.11% and over the past year by +12.59%.
Over the past week, the price has changed by -1.32%, over one month by +10.30%, over three months by +21.11% and over the past year by +12.59%.
Is MPTI a buy, sell or hold?
M-tron Industries has no consensus analysts rating.
What are the forecasts/targets for the MPTI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 69 | 7.2% |
| Analysts Target Price | 69 | 7.2% |
| ValueRay Target Price | 87.7 | 36.2% |
MPTI Fundamental Data Overview February 02, 2026
P/E Trailing = 26.413
P/E Forward = 16.3666
P/S = 3.6072
P/B = 5.029
P/EG = 0.6192
Revenue TTM = 53.0m USD
EBIT TTM = 9.20m USD
EBITDA TTM = 10.2m USD
Long Term Debt = 159.0k USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 9000 USD (from shortTermDebt, last fiscal year)
Debt = 159.0k USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -18.2m USD (from netDebt column, last quarter)
Enterprise Value = 173.0m USD (191.1m + Debt 159.0k - CCE 18.3m)
Interest Coverage Ratio = -21.24 (Ebit TTM 9.20m / Interest Expense TTM -433.0k)
EV/FCF = 24.15x (Enterprise Value 173.0m / FCF TTM 7.16m)
FCF Yield = 4.14% (FCF TTM 7.16m / Enterprise Value 173.0m)
FCF Margin = 13.52% (FCF TTM 7.16m / Revenue TTM 53.0m)
Net Margin = 13.51% (Net Income TTM 7.16m / Revenue TTM 53.0m)
Gross Margin = 44.40% ((Revenue TTM 53.0m - Cost of Revenue TTM 29.5m) / Revenue TTM)
Gross Margin QoQ = 44.31% (prev 43.61%)
Tobins Q-Ratio = 4.10 (Enterprise Value 173.0m / Total Assets 42.2m)
Interest Expense / Debt = 39.62% (Interest Expense 63.0k / Debt 159.0k)
Taxrate = 33.70% (931.0k / 2.76m)
NOPAT = 6.10m (EBIT 9.20m * (1 - 33.70%))
Current Ratio = 6.90 (Total Current Assets 34.9m / Total Current Liabilities 5.06m)
Debt / Equity = 0.00 (Debt 159.0k / totalStockholderEquity, last quarter 37.0m)
Debt / EBITDA = -1.77 (Net Debt -18.2m / EBITDA 10.2m)
Debt / FCF = -2.54 (Net Debt -18.2m / FCF TTM 7.16m)
Total Stockholder Equity = 34.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 19.42% (Net Income 7.16m / Total Assets 42.2m)
RoE = 21.02% (Net Income TTM 7.16m / Total Stockholder Equity 34.1m)
RoCE = 26.88% (EBIT 9.20m / Capital Employed (Equity 34.1m + L.T.Debt 159.0k))
RoIC = 17.90% (NOPAT 6.10m / Invested Capital 34.1m)
WACC = 11.07% (E(191.1m)/V(191.3m) * Re(11.06%) + D(159.0k)/V(191.3m) * Rd(39.62%) * (1-Tc(0.34)))
Discount Rate = 11.06% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 2.53%
[DCF Debug] Terminal Value 71.94% ; FCFF base≈6.56m ; Y1≈8.09m ; Y5≈13.8m
Fair Price DCF = 54.88 (EV 142.6m - Net Debt -18.2m = Equity 160.8m / Shares 2.93m; r=11.07% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 39.67 | EPS CAGR: -38.04% | SUE: -2.65 | # QB: 0
Revenue Correlation: 96.77 | Revenue CAGR: 21.34% | SUE: 0.14 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.63 | Chg30d=+0.035 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=2.71 | Chg30d=+0.150 | Revisions Net=+0 | Growth EPS=+13.9% | Growth Revenue=+11.6%
P/E Forward = 16.3666
P/S = 3.6072
P/B = 5.029
P/EG = 0.6192
Revenue TTM = 53.0m USD
EBIT TTM = 9.20m USD
EBITDA TTM = 10.2m USD
Long Term Debt = 159.0k USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 9000 USD (from shortTermDebt, last fiscal year)
Debt = 159.0k USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -18.2m USD (from netDebt column, last quarter)
Enterprise Value = 173.0m USD (191.1m + Debt 159.0k - CCE 18.3m)
Interest Coverage Ratio = -21.24 (Ebit TTM 9.20m / Interest Expense TTM -433.0k)
EV/FCF = 24.15x (Enterprise Value 173.0m / FCF TTM 7.16m)
FCF Yield = 4.14% (FCF TTM 7.16m / Enterprise Value 173.0m)
FCF Margin = 13.52% (FCF TTM 7.16m / Revenue TTM 53.0m)
Net Margin = 13.51% (Net Income TTM 7.16m / Revenue TTM 53.0m)
Gross Margin = 44.40% ((Revenue TTM 53.0m - Cost of Revenue TTM 29.5m) / Revenue TTM)
Gross Margin QoQ = 44.31% (prev 43.61%)
Tobins Q-Ratio = 4.10 (Enterprise Value 173.0m / Total Assets 42.2m)
Interest Expense / Debt = 39.62% (Interest Expense 63.0k / Debt 159.0k)
Taxrate = 33.70% (931.0k / 2.76m)
NOPAT = 6.10m (EBIT 9.20m * (1 - 33.70%))
Current Ratio = 6.90 (Total Current Assets 34.9m / Total Current Liabilities 5.06m)
Debt / Equity = 0.00 (Debt 159.0k / totalStockholderEquity, last quarter 37.0m)
Debt / EBITDA = -1.77 (Net Debt -18.2m / EBITDA 10.2m)
Debt / FCF = -2.54 (Net Debt -18.2m / FCF TTM 7.16m)
Total Stockholder Equity = 34.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 19.42% (Net Income 7.16m / Total Assets 42.2m)
RoE = 21.02% (Net Income TTM 7.16m / Total Stockholder Equity 34.1m)
RoCE = 26.88% (EBIT 9.20m / Capital Employed (Equity 34.1m + L.T.Debt 159.0k))
RoIC = 17.90% (NOPAT 6.10m / Invested Capital 34.1m)
WACC = 11.07% (E(191.1m)/V(191.3m) * Re(11.06%) + D(159.0k)/V(191.3m) * Rd(39.62%) * (1-Tc(0.34)))
Discount Rate = 11.06% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 2.53%
[DCF Debug] Terminal Value 71.94% ; FCFF base≈6.56m ; Y1≈8.09m ; Y5≈13.8m
Fair Price DCF = 54.88 (EV 142.6m - Net Debt -18.2m = Equity 160.8m / Shares 2.93m; r=11.07% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 39.67 | EPS CAGR: -38.04% | SUE: -2.65 | # QB: 0
Revenue Correlation: 96.77 | Revenue CAGR: 21.34% | SUE: 0.14 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.63 | Chg30d=+0.035 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=2.71 | Chg30d=+0.150 | Revisions Net=+0 | Growth EPS=+13.9% | Growth Revenue=+11.6%